Investor Presentation • Aug 16, 2022
Investor Presentation
Open in ViewerOpens in native device viewer


This presentation, which includes oral statements made or videos shown at the presentation hereof, any question and answer session and any written or oral material discussed or distributed during the meeting to present this document or otherwise in connection with it (this "Presentation") contains confidential information regarding MAX Stock Ltd. ("MAX" or "the Company") and is being provided on a strictly confidential basis. This Presentation has been prepared by MAX for information purposes only and may not be used in making any investment decision. This Presentation is strictly confidential and may not be copied, reproduced, redistributed or passed on, in whole or in part, or disclosed, directly or indirectly, to any other person or published or for any purpose. This Presentation is not intended fordistribution to, or use by any person or entity in, any jurisdiction or country where such distribution or use would be contrary to local law or regulation. This Presentation was prepared solely based on information obtained from MAX and public sources (including data obtained by MAX from industry publications and surveys) on or prior to the date hereof and has not been independently verified. MAX may not have access to the facts and assumptions underlying the numerical data, market data and other information included in such surveys. This Presentation only contains summary information and no representation or warranty, express or implied, is or will be made in relation to and no reliance should be placed on the fairness, accuracy, correctness or completeness of the information or opinions contained in this Presentation.
Except where otherwise indicated herein, the information provided in the presentation is based on matters as they exist as ofthe date of preparation of this presentation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available, or circumstances existing or changes occurring after the date hereof.
This presentation contains forward-looking statements within the meaning of Section 27a of the Securities act, Section 21E of the U.S. Securities Exchange Act of 1934, and the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that relate to our current expectations and views of future events. These statements relate to events that involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. in some cases, forward-looking statements can be identified by the use of forward-looking terminology such as "may," "will," "should," "expect," "anticipate," "target," "project," "estimate," "intend," "continue" or "believe," or the negatives thereof or other variations thereon or comparable terminology.
Actual events or results or the actual performance of Max may differ materially from those reflected or contemplated in any suchforward-looking statements. No representation or warranty is made as to future performance or any forward-looking statement. Certain market data information in this presentation is based on management's estimates. Max believes its estimates to be accurate as of the date of this presentation. However, this information may prove to be inaccurate because of the method by which Max obtained some of the data for its estimates or because this information cannot always be verified dueto the limits on the availability and reliability of raw data.
Statements contained in this Presentation may relate to the historical experience of our founders, managers and directors. The historical results of our founders', managers' and directors' past investments, companies or funds affiliated with them is not necessarily indicative of the future performance of Max.
This Presentation does not constitute and is not intended to form part of any offer, or the solicitation of any offer, to buy, subscribe for or sell any securities in MAX or any subsidiary of MAX and nothing in this Presentation shall in any way constitute or form part of any legal agreement or be relied on in connection with, any contract, commitment or investment decision. Each recipient of the information contained in this Presentation is responsible for making its own independent assessment of the business, financial condition, prospects, status and affairs of MAX. No person shall have any right of action against MAX or any other person in relation to the accuracy or completeness of the information contained in the Presentation.
This Presentation and the information contained herein are not a solicitation of an offer to buy securities or an offer for the sale of securities in Israel, in the United States or in any other jurisdiction in which such solicitation or offer are not allowed. MAX has not and does not expect to register any securities that it may offer under the United States SecuritiesAct of 1933, or the securities laws of any state of the United States or any other jurisdiction, and any such securities may not be offered or sold in the United States absent registration under the Securities Act or an available exemption from registration.
This Presentation does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC. This Presentation is only addressed to and directed at persons in member states of the European Economic Area (the "EEA") who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation ("Qualified Investors"). In addition, in the United Kingdom, this Presentation is only being distributed to and is directed only at Qualified Investors who (i) have professional experience in matters relating to investments who fall within the definition of "investment professionals" under Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) are high net worth entities and fall within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "Relevant Persons"). This Presentation and its contents must not be acted on or relied upon (i) in the United Kingdom, by persons who are not Relevant Persons or (ii) in any member state of the EEA (other than the United Kingdom), by persons who are not Qualified Investors. The communication of this Presentation (i) in the United Kingdom to persons who are not Relevant Persons or (ii) in any member state of the EEA (other than the UnitedKingdom) to persons who are not Qualified Investors is unauthorized and may contravene applicable law. Nothing in this Presentation constitutes investment advice and any recommendations that may be contained herein have not been based upon a consideration of the investment objectives, financial situation or particular needs of any specific recipient. If you have received this Presentation and you are (i) in the EEA (other than the United Kingdom) and are not a Qualified Investor or (ii) in the United Kingdom and are not a Relevant Person, you must return it immediately to MAX. By attending this Presentation and/or receiving this document, you are agreeing to the terms and conditions set forth above.
This presentation includes certain financial measures not presented in accordance with International Financial Reporting Standards ("IFRS"), including Adjusted EBITDA. These financial measures are not measures of financial performance in accordance with IFRS and may exclude items that are significant in understanding and assessing the Company's financial results. Therefore, these measures should not be considered in isolation or as an alternative to net loss or other measures of profitability, liquidity or performance under IFRS. You should be aware that the Company's presentation of these measures may not be comparable to similarly titled measures used by other companies, which may be defined and calculated differently. See the appendix for a reconciliation of certain of these non-IFRS measures to the most directly comparable IFRS measure.
The trademarks included herein are the property of the owners thereof and are used for reference purposes only. Such use should not be construed as an endorsement of the products or services of the Company or the proposed offering.
We are Israel 's leading extreme value retailer









Major Categories




| +2.8% | +13.0% | 39.3% | NIS 56mm | NIS 45mm |
|---|---|---|---|---|
| SSSG +18.1% vs. Q2'2019 |
Revenue growth +41.9% vs. Q2'2019 Q2'19-Q2'22 CAGR: 12.4% |
Gross Margins +100bps vs. Q2'2021 -160bps vs. Q2'2019 Q2'19-Q2'22 Gross Profit CAGR: 10.9% |
Operating Cash Flow Vs. NIS 10mm in Q2'2021, mainly due to inventory levels intentionally going down |
NIS 40mm in Dividends to be paid on th Sep. 6 / NIS 0.28 per share; Plus ~NIS 5mm to date in share buyback |

| -3.8% | +5.9% | 39.1% | NIS 61mm | NIS 0.23 |
|---|---|---|---|---|
| SSSG +19.9% vs. H1'2019 |
Revenue growth +43.0% vs. H1'2019 H1'19-H1'22 CAGR: 12.7% |
Gross Margins +10bps vs. H1'2021 -70bps vs. H1'2019 H1'19-H1'22 Gross Profit CAGR: 12.1% |
Adj. EBITDA (1) Vs. NIS 73mm in H1'2021, reflecting higher Opex; H1'19-H1'22 Adj. EBITDA CAGR: 6.7% |
(2) Adj. EPS Vs. NIS 0.32 in H1'2021, reflecting higher Opex H1'19-H1'22 Adj. EPS CAGR: 3.1% |
% of H1'22 NIS Revenue and YoY growth


We Offer the Lowest Prices On Backto-School Items


Corporate Social Responsibility Initiatives


We strive to make our branches accessible to populations with disabilities, also via working with RightHear, which works to make businesses accessible to blind consumers through innovative technology

Over 3% of our employees are with disabilities and belong to various associations that support their social integration

Our employees participate in several volunteering events throughout the year

| We adopted a donation policy, according to |
|---|
| which we contribute to several institutions and |
| associations of various types, such as |
| hospitals, children's institutions or institutions |
that provide food to families in need
11








* Excluding one-time bulk operations in 2020.
(1) Adjusted EBITDA pre IFRS 16 = EBIT + D&A + other costs (including IPO costs in 2020) + stock-based compensation (SBC) – one-time bulk operation (in 2020) – the impact of IFRS 16. 16
(2) Net Income (NI) and EPS (both attributable to shareholders) adjusted for stock-based compensation (SBC), one-time bulk operation in 2020 and IPO costs in 2020.


(Q2'19; Q2'20; Bridge from Q2'21 to Q2'22; NIS mm)


+9.0% vs. Q2'19
Evolution of Inventory and Inventory per Owned Net SqM (Q4'20-Q2'22)






* Excluding one-time bulk operations in 2020.
(1) Adjusted EBITDA pre IFRS 16 = EBIT + D&A + other costs (including IPO costs in 2020) + stock-based compensation (SBC) + one-time bulk operation (in 2020) – the impact of IFRS 16. 20
(2) Net Income (NI) and EPS (both attributable to shareholders) adjusted for stock-based compensation (SBC), one-time bulk operation in 2020 and IPO costs in 2020.



+43.0% vs. H1'19
(H1'19; H1'20; Bridge from H1'21 to H1'22; NIS mm)


+21.6% vs. H1'19
(2019 - Last Twelve Months Q2'2022)



* Excluding one-time bulk operations in 2020.
(1) Adjusted EBITDA pre IFRS 16 = EBIT + D&A + other costs (including IPO costs in 2020) + stock-based compensation (SBC) – one-time bulk operation (in 2020) – the impact of IFRS 16. 23
(2) EPS adjusted for stock-based compensation (SBC), one-time bulk operation in 2020 and IPO costs in 2020. % of Revenue represents Adjusted Net Income attributable to shareholders / Revenue.



Chief Corporate Development & IR Officer +972-50-7000155
Dream Big, Pay Small


| 2019 Q2 |
2020 Q2 |
2021 Q2 |
2022 Q2 |
|
|---|---|---|---|---|
| from sales Revenue |
176.7 | 172.9 | * 220.7 |
249.2 |
| / from commissions fees Revenue |
1.3 | 1.2 | * 2.9 |
3.5 |
| Total Revenue |
178.1 | 174.2 | 223.6 | 252.7 |
| YoYgrowth | -2.2% | 28.4% | 13.0% | |
| from onetime bulk operation Revenue |
0.0 | 112.2 | 0.0 | 0.0 |
| Total Revenue |
178.1 | 286.4 | 223.6 | 252.7 |
| YoYgrowth | 60.8% | -21.9% | 13.0% | |
| profit, Gross excluding onetime bulk operation |
72.8 | 67.2 | 85.6 | 99.2 |
| % of Revenue |
40.9% | 38.6% | 38.3% | 39.3% |
| profit onetime bulk operation Gross |
9.7 | |||
| % of bulk onetime operation |
8.6% | |||
| S&M | 40.5 | 30.9 | 47.3 | 61.1 |
| G&A | 5.2 | 6.0 | 9.6 | 13.4 |
| Total SG&A |
45.7 | 36.9 | 57.0 | 74.5 |
| Less: SBC |
0.0 | (3.9) | (3.8) | |
| excluding SG&A SBC |
45.7 | 36.9 | 53.1 | 70.6 |
| % of bulk Revenue, excluding onetime operation |
25.7% | 21.2% | 23.8% | 28.0% |
| % of Revenue |
25.7% | 12.9% | 23.8% | 28.0% |
| income Other |
(0.4) | (0.5) | (1.6) | 0.0 |
| Other expenses |
0.0 | 0.0 | 0.0 | 0.0 |
| GAAP EBIT |
27.4 | 40.4 | 30.2 | 24.7 |
| % of Revenue |
15.4% | 14.1% | 13.5% | 9.8% |
| Adj. (exc. onetime and other) EBIT SBC, |
27.1 | 30.3 | 32.5 | 28.6 |
| % of Revenue |
15.2% | 17.4% | 14.5% | 11.3% |


| NIS | mm |
|---|---|
| ----- | ---- |
| mm NIS |
2019 Q2 |
2020 Q2 |
2021 Q2 |
2022 Q2 |
|
|---|---|---|---|---|---|
| Interest expenses, net |
2.4 | 5.8 | 4.7 | 4.6 | |
| Interest expenses onetime bulk operation |
0.0 | 8.4 | 0.0 | 0.0 | |
| EBT | 25.0 | 26.3 | 25.5 | 20.1 | |
| (exc, onetime other) Adj. SBC, and EBT |
24.6 | 24.5 | 27.8 | 23.9 | |
| Taxes | 5.8 | 6.4 | 7.1 | 5.7 | |
| GAAP Net Income |
19.2 | 19.9 | 18.4 | 14.4 | |
| % ofRevenue | 10.8% | 7.0% | 8.2% | 5.7% | |
| for Income (adjusted one-time operation Adj. Net SBC, bulk in |
|||||
| costs 2020 and 2020) IPO in |
19.2 | 18.9 | 22.3 | 18.3 | |
| % ofRevenue | 10.8% | 10.8% | 10.0% | 7.2% | |
| shareholders income attributable to Net |
16.3 | 16.3 | 14.9 | 11.3 | |
| non-controlling interests income attributable to Net |
2.9 | 3.6 | 3.5 | 3.1 | |
| 19.2 | 19.9 | 18.4 | 14.4 | ||
| Income Adjustments: Net |
|||||
| SBC | 0.0 | 0.0 | 3.9 | 3.8 | |
| of Onetime bulk operation, net taxes |
0.0 | (1.0) | 0.0 | 0.0 | |
| Total Income Adjustments Net |
0.0 | (1.0) | 3.9 | 3.8 | |
| Attributable to shareholders Adjusted Net Income - |
16.3 | 15.3 | 18.8 | 15.2 | |
| Attributable to non-controlling interests Adjusted Net Income - |
2.9 | 3.6 | 3.5 | 3.1 | |
| Adjusted Net Income |
19.2 | 18.9 | 22.3 | 18.3 | |
| (000s) Basic Shares O/S |
142.3 | 142.3 | 142.3 | 142.0 | |
| attributable to shareholders EPS, |
0.11 | 0.11 | 0.10 | 0.08 | |
| to Adj. attributable shareholders EPS |
0.11 | 0.11 | 0.13 | 0.11 |
Note: Totals may be sightly impacted by minor rounding differences.

| 2019 Q2 |
2020 Q2 |
2021 Q2 |
2022 Q2 |
|
|---|---|---|---|---|
| Net Income |
19.2 | 19.9 | 18.4 | 14.4 |
| Interest net Plus Expense, |
2.4 | 14.1 | 4.7 | 4.6 |
| Income Taxes Plus |
5.8 | 6.4 | 7.1 | 5.7 |
| Plus D&A |
9.6 | 9.4 | 12.6 | 16.4 |
| Other Plus Expense |
(0.4) | (0.5) | (1.6) | 0.0 |
| (exc. Other EBITDA Post 16 Expenses) IFRS |
36.7 | 49.4 | 41.2 | 41.1 |
| Plus SBC |
0.0 | 0.0 | 3.9 | 3.8 |
| Minus IFRS 16 |
(9.8) | (10.2) | (14.3) | (15.6) |
| Adjusted Pre 16 (exc. Other EBITDA IFRS SBC and |
||||
| Expenses) | 26.9 | 39.1 | 30.7 | 29.3 |
| operation Onetime bulk |
0.0 | (9.7) | 0.0 | 0.0 |
| Adjusted Pre excluding onetime bulk EBITDA 16, IFRS |
||||
| operation | 26.9 | 29.5 | 30.7 | 29.3 |
| of Revenue % |
15.1% | 16.9% | 13.7% | 11.6% |
| 2019 H1 |
2020 H1 |
2021 H1 |
2022 H1 |
|
|---|---|---|---|---|
| from sales Revenue |
349.4 | 345.2 | * 469.3 |
496.4 |
| / from commissions Revenue fees |
2.7 | 2.4 | * 6.3 |
7.2 |
| Total Revenue, excluding onetime bulk operation |
352.1 | 347.6 | 475.6 | 503.6 |
| YoY growth |
-1.3% | 36.8% | 5.9% | |
| from onetime bulk operation Revenue |
0.0 | 124.8 | 0.0 | 0.0 |
| Total Revenue |
352.1 | 472.4 | 475.6 | 503.6 |
| YoY growth |
34.2% | 0.7% | 5.9% | |
| profit operation) Gross (Excluding onetime bulk |
140.0 | 136.9 | 185.4 | 197.0 |
| % of bulk Revenue (Excluding onetime operation) |
39.8% | 39.4% | 39.0% | 39.1% |
| profit onetime bulk operation Gross |
14.3 | |||
| % ofRevenue | 11.5% | |||
| S&M | 78.2 | 69.9 | 95.8 | 118.7 |
| G&A | 11.1 | 11.9 | 21.9 | 25.9 |
| Total SG&A |
89.3 | 81.8 | 117.7 | 144.6 |
| Less: SBC |
0.0 | (7.7) | (7.7) | |
| excluding SG&A SBC |
89.3 | 81.8 | 110.0 | 136.9 |
| % of excluding onetime bulk operation Revenue, |
25.4% | 23.5% | 23.1% | 27.2% |
| % of Revenue |
25.4% | 17.3% | 23.1% | 27.2% |
| income Other |
(0.4) | (0.5) | (1.6) | (0.3) |
| Other expenses, net |
0.0 | 0.0 | 0.0 | 0.1 |
| EBIT | 51.1 | 69.9 | 69.3 | 52.6 |
| % ofRevenue | 14.5% | 14.8% | 14.6% | 10.4% |
| Adj. (exc. onetime and other) EBIT SBC, |
50.7 | 55.1 | 75.4 | 60.1 |
| % of excluding onetime bulk operation Revenue, |
14.4% | 15.8% | 15.8% | 11.9% |
| H12019 | H12020 | H12021 | H12022 | |
|---|---|---|---|---|
| Interest expenses, net |
4.9 | 7.9 | 7.6 | 9.1 |
| Interest expenses onetime bulk operation |
11.8 | |||
| EBT | 46 | 50.2 | 61.7 | 43.5 |
| Adj. (exc, onetime other) SBC, and EBT |
46 | 47.2 | 67.8 | 51.1 |
| Taxes | 10.8 | 12.2 | 16.3 | 12.0 |
| GAAP Net Income |
35 | 38.0 | 45.4 | 31.5 |
| % ofRevenue | 10.0% | 8.0% | 9.5% | 6.2% |
| for Income operation Adj. Net (adjusted one-time bulk SBC, in |
||||
| costs 2020 and 2020) IPO in |
35 | 36 | 53 | 39 |
| % ofRevenue, excluding onetime bulk operation |
10.0% | 10.4% | 11.2% | 7.8% |
| to Net Income - Attributable shareholders |
30.0 | 32.5 | 37.3 | 25.3 |
| to Net Income - Attributable non-controlling interests |
5.4 | 5.5 | 8.1 | 6.2 |
| GAAP Net Income |
35.4 | 38.0 | 45.4 | 31.5 |
| Net Income Adjustments: |
||||
| of Total income adjustments, net taxes - one-time net bulk |
||||
| operation | (1.9) | |||
| SBC | 7.7 | 7.7 | ||
| Total Net Income Adjustments: |
0.0 | (1.9) | 7.7 | 7.7 |
| Adjusted Net Income - Attributable to shareholders |
30.0 | 30.6 | 45.0 | 33.0 |
| to Adjusted Net Income - Attributable non-controlling interests |
5.4 | 5.5 | 8.1 | 6.2 |
| Adjusted Net Income |
35.4 | 36.0 | 53.1 | 39.2 |
| Basic Shares O/S |
142.3 | 142.3 | 142.3 | 142.3 |
| attributable to shareholders EPS, |
0.21 | 0.23 | 0.26 | 0.18 |
| Adj. attributable to EPS shareholders |
0.21 | 0.21 | 0.32 | 0.23 |



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.